KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Inventory (2017 - 2025)

Guardant Health's Change in Inventory history spans 9 years, with the latest figure at -$4.6 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 280.07% year-over-year to -$4.6 million; the TTM value through Dec 2025 reached $14.8 million, up 61.93%, while the annual FY2025 figure was $14.8 million, 61.93% up from the prior year.
  • Change in Inventory for Q4 2025 was -$4.6 million at Guardant Health, down from $6.4 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $23.3 million in Q2 2022 and bottomed at -$15.1 million in Q4 2023.
  • The 5-year median for Change in Inventory is $4.7 million (2024), against an average of $3.2 million.
  • The largest YoY upside for Change in Inventory was 1077.37% in 2022 against a maximum downside of 292.94% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $5.9 million in 2021, then crashed by 292.94% to -$11.4 million in 2022, then plummeted by 31.76% to -$15.1 million in 2023, then surged by 91.95% to -$1.2 million in 2024, then crashed by 280.07% to -$4.6 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Change in Inventory are -$4.6 million (Q4 2025), $6.4 million (Q3 2025), and $6.8 million (Q2 2025).